G01N2800/7052 - CPC Classification Index

#1

20260008845

2026-01-08

BIOMARKERS FOR FIBROSIS TREATMENT USING ANTI-CLAUDIN-1 ANTIBODIES

#2

20250369988

2025-12-04

CD146 AND USES THEREOF AS A BIOMARKER AND AS A THERAPEUTIC TARGET IN THE DIAGNOSIS AND TREATMENT OF FIBROSIS

#3

20250011405

2025-01-09

TREATMENT AND DIAGNOSIS OF DISEASES ASSOCIATED TO PATHOGENIC FIBROSIS

#4

20250009747

2025-01-09

ENDOTHELIN RECEPTOR ANTAGONISTS FOR USE IN TREATING OR PREVENTING MUSCLE FIBROSIS

#5

20240125802

2024-04-18

Immunoassay for Detecting Eosinophilic Esophagitis

#6

20240003906

2024-01-04

Biomarker of Fibrosis

#7

20230059874

2023-02-23

NEW PROTEIN MARKERS OF RENAL DAMAGE

#8

20220334131

2022-10-20

CIRCULATING BIOMARKERS OF PRECLINICAL PULMONARY FIBROSIS

#9

20220296688

2022-09-22

TARGETING CAPN9/CAPNS2 ACTIVITY AS A THERAPEUTIC STRATEGY FOR THE TREATMENT OF MYOFIBROBLAST DIFFERENTIATION AND ASSOCIATED PATHOLOGIES

#10

20220221472

2022-07-14

METHOD FOR DIAGNOSING ENDOMETRIOSIS, DISEASE STATE MONITORING METHOD, AND KIT

#11

20220205039

2022-06-30

Combination of biomarkers for detecting and evaluating a hepatic fibrosis

#12

20220196635

2022-06-23

Fibrosis Assay

#13

20220003784

2022-01-06

CD146 AND USES THEREOF AS A BIOMARKER AND AS A THERAPEUTIC TARGET IN THE DIAGNOSIS AND TREATMENT OF FIBROSIS

#14

20210309729

2021-10-07

Netrin G1 as a biomarker for enhancing tumor treatment efficacy

#15

20200378971

2020-12-03

Elastin Assay

#16

20200368271

2020-11-26

METHOD AND APPARATUS FOR ADMINISTERING GASES INCLUDING NITRIC OXIDE

#17

20200368247

2020-11-26

CENICRIVIROC FOR THE TREATMENT OF FIBROSIS

#18

20200268768

2020-08-27

CENICRIVIROC COMBINATION THERAPY FOR THE TREATMENT OF FIBROSIS

#19

20200263178

2020-08-20

Compositions and methods for treating hepatic fibrosis

#20

20200256866

2020-08-13

Devices and methods related to airway inflammation

#21

20200251214

2020-08-06

Liver Fibrosis Assessment Model, Liver Fibrosis Assessment System And Liver Fibrosis Assessment Method

#22

20200110088

2020-04-09

Diagnosis and treatment of viral diseases

#23

20200056235

2020-02-20

COMBINATION OF BIOMARKERS FOR DETECTING AND EVALUATING A HEPATIC FIBROSIS

#24

20200055896

2020-02-20

SUBSTRATES RECOGNIZED BY FIBROBLAST ACTIVATION PROTEIN (FAP) AND METHODS OF USING THE SAME

#25

20190219560

2019-07-18

METHOD FOR MEASURING A BIOLOGICAL VALUE OF A LIVER

#26

20190099429

2019-04-04

CENICRIVIROC FOR THE TREATMENT OF FIBROSIS

#27

20180318405

2018-11-08

Targeting CAPN9/CAPNS2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies

#28

20180280476

2018-10-04

DIAGNOSTIC BIOMARKERS FOR FIBROTIC DISORDERS

#29

20180267060

2018-09-20

Biochemical Markers for Pulmonary and Other Diseases

#30

20180180615

2018-06-28

Diagnosis and treatment of viral diseases

#31

20180100867

2018-04-12

Method for Discriminating Symptom of Hepatic Disease

#32

20180085466

2018-03-29

Optical probes for matrix metalloproteinases

#33

20170370954

2017-12-28

Biomarkers for Fatty Liver Disease and Methods Using the Same

#34

20170337322

2017-11-23

Non-invasive method for assessing liver fibrosis progression

#35

20170333517

2017-11-23

Compositions and methods for inhibiting fibrosis

#36

20170327595

2017-11-16

THERAPEUTIC AND DIAGNOSTIC METHODS RELATED TO LYSYL OXIDASE-LIKE 2 (LOXL2)

#37

20170283871

2017-10-05

Combination of biomarkers for detecting and evaluating a hepatic fibrosis

#38

20170239262

2017-08-24

CENICRIVIROC FOR THE TREATMENT OF FIBROSIS

#39

20170168053

2017-06-15

Diagnosis and treatment of viral diseases

#40

20170138967

2017-05-18

METABOLICS BIOMARKER FOR NAFLD AND METHODS OF USE

#41

20160341714

2016-11-24

METHOD FOR MEASURING A BIOLOGICAL VALUE OF A LIVER

#42

20160334416

2016-11-17

Biochemical markers for pulmonary and other diseases

#43

20160251414

2016-09-01

Anti-LPS enriched immunoglobulin for use in treatment and/or prophylaxis of fibrosis

#44

20160223568

2016-08-04

Combined biomarker measurement of fibrosis

#45

20160202252

2016-07-14

Devices and methods related to airway inflammation

#46

20160159918

2016-06-09

METHODS FOR DIAGNOSING AND TREATING IMMUNE DISEASE

#47

20160074374

2016-03-17

CORRECTORS ACTING THROUGH MSD1 OF CFTR PROTEIN

#48

20160061844

2016-03-03

PIIINP neo-epitope assay

#49

20150344976

2015-12-03

Diagnosis and treatment of viral diseases

#50

20130323720

2013-12-05

Combination of biomarkers for the detection and evaluation of hepatitis fibrosis

#51

20130053429

2013-02-28

Treatment of fibrosis using microRNA 19b

#52

20120316240

2012-12-13

METHOD OF DIAGNOSIS

#53

20120270246

2012-10-25

Procollagen C-proteinase enhancer (PCPE) biomarker for bone formation

#54

20120015368

2012-01-19

BIOMARKERS FOR EARLY DIAGNOSIS OF SYSTEMIC TISSUE FIBROSIS

#55

20120010824

2012-01-12

Non-Invasive Method for Assessing Liver Fibrosis Progression

#56

20100221746

2010-09-02

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE

#57

20090226460

2009-09-10

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE